Anti-CD20 antibody as Initial therapy for adult-onset minimal change disease with nephrotic syndrome：a case series reportShuang-xi Li MD1, Jing Xu MD1*1Department of nephrology, Changhai Hospital, the Naval Medical University, Shanghai, China;*Correspondence author :Jing Xu, Department of Nephrology, Changhai Hospital, 168 Changhai Rd，Shanghai, China; 200433. E-mail: [email protected] : MCD：minimal change disease；NS: nephrotic syndrome; CyC: cyclophosphamide; Cys: cyclosporine; TAC: tacrolimus; RTX: rituximab; OTZ: obinutuzumab; IGT: impaired glucose tolerance; ALB: albumin; TG: tolal cholesterol; TC: triglycerides; WBC: white blood cell；Scr: serum creatinine; PR: partial remission; CR:complete remission; AE:adverse eventsKeywords : minimal change disease; CD20; nephrotic syndrome; rituximab; obinutuzumab